NUMA1 and Sjogren syndrome: Additionally, individuals with primary Sjogren's syndrome or SLE who also have anti-NuMA antibodies tend to have less severe clinical symptoms and laboratory findings, suggesting that NuMA antibodies may be a positive prognostic marker [12].